These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 25032885)
1. Pharmacotherapy for hyperammonemia. Hadjihambi A; Khetan V; Jalan R Expert Opin Pharmacother; 2014 Aug; 15(12):1685-95. PubMed ID: 25032885 [TBL] [Abstract][Full Text] [Related]
2. [Prevention and treatment of hepatic encephalopathy]. Sivolap YP Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy. Ahire K; Sonawale A J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305 [TBL] [Abstract][Full Text] [Related]
4. Nontraditional Treatment of Hepatic Encephalopathy. Singh J; Ibrahim B; Han SH Clin Liver Dis; 2024 May; 28(2):297-315. PubMed ID: 38548441 [TBL] [Abstract][Full Text] [Related]
5. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure. Kristiansen RG Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377 [TBL] [Abstract][Full Text] [Related]
6. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Jalan R; Wright G; Davies NA; Hodges SJ Med Hypotheses; 2007; 69(5):1064-9. PubMed ID: 17467190 [TBL] [Abstract][Full Text] [Related]
7. Update on the Therapeutic Management of Hepatic Encephalopathy. Kornerup LS; Gluud LL; Vilstrup H; Dam G Curr Gastroenterol Rep; 2018 Apr; 20(5):21. PubMed ID: 29644492 [TBL] [Abstract][Full Text] [Related]
17. Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatments. Eriksen PL; Djernes L; Vilstrup H; Ott P J Hepatol; 2023 Aug; 79(2):340-348. PubMed ID: 37061198 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study. Poo JL; Góngora J; Sánchez-Avila F; Aguilar-Castillo S; García-Ramos G; Fernández-Zertuche M; Rodríguez-Fragoso L; Uribe M Ann Hepatol; 2006; 5(4):281-8. PubMed ID: 17151582 [TBL] [Abstract][Full Text] [Related]